Enzolytics Stock Price, News & Analysis
Company Description
Enzolytics (OTC Link: ENZC) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.9M.
ENZC stock has declined 57.1% over the past year. Shares last traded at $0.0003.
This page provides a comprehensive overview of ENZC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Enzolytics (ENZC) stock last traded at $0.0003. Over the past 12 months, the stock has lost 57.1%. At a market capitalization of $1.9M, ENZC is classified as a micro-cap stock with approximately 4.8B shares outstanding.
Latest News
Enzolytics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, partnership. View all ENZC news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Enzolytics (ENZC) currently stands at 677.5 thousand shares, up 324082.8% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 515.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Enzolytics (ENZC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
ENZC Company Profile & Sector Positioning
Enzolytics (ENZC) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ENZC often look at related companies in the same sector, including Neon Bloom (NBCO), Algernon Health (AGNPF), Axim Biotechnologies Inc (AXIM), Vaccinex Inc (VCNX), and Restart Life (NMLSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ENZC's relative position within its industry.